Acute lymphoblastic leukaemia
- 7 June 2013
- journal article
- review article
- Published by Elsevier BV in The Lancet
- Vol. 381 (9881), 1943-1955
- https://doi.org/10.1016/s0140-6736(12)62187-4
Abstract
No abstract availableKeywords
This publication has 131 references indexed in Scilit:
- MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1LCancer Cell, 2011
- CREBBP mutations in relapsed acute lymphoblastic leukaemiaNature, 2011
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine DosingClinical Pharmacology & Therapeutics, 2011
- Glucocorticoid use in acute lymphoblastic leukaemiaThe Lancet Oncology, 2010
- L‐asparaginase treatment in acute lymphoblastic leukemiaCancer, 2010
- Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysisThe Lancet Oncology, 2010
- A phase II study of Campath-1H in children with relapsed or refractory acute lymphoblastic leukemia: A Children's Oncology Group reportPediatric Blood & Cancer, 2009
- A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification studyThe Lancet Oncology, 2009
- Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemiaThe Lancet Oncology, 2009
- Genome-wide Interrogation of Germline Genetic Variation Associated With Treatment Response in Childhood Acute Lymphoblastic LeukemiaJAMA, 2009